Mediclinic is an international private healthcare group founded in 1983, with operations in Southern Africa (South African
and Namibia), Switzerland and the United Arab Emirates. The Company’s primary listing is on the LSE in
the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia. The Group’s
registered office is in London, United Kingdom. Mediclinic also holds a 29.9% interest in Spire Healthcare
Group plc, an LSE-listed private healthcare group based in the United Kingdom.
Mediclinic is focused on providing acute care, specialist-orientated, multi-disciplinary healthcare services. Our core purpose
is to enhance the quality of life of our patients by providing comprehensive, high-quality healthcare
services in such a way that the Group will be regarded as the most respected and trusted provider of
healthcare services by patients, doctors and funders of healthcare in each of its markets.
During February 2016, the Combination of the Company (previously named Al Noor Hospitals Group plc), with operations mainly
in Abu Dhabi in the United Arab Emirates, and Mediclinic International Limited was completed. Mediclinic
International Limited was a South African-based international private healthcare group founded in 1983
and listed on the JSE, the South African stock exchange, since 1986, with operations in South Africa,
Namibia, Switzerland and the United Arab Emirates (mainly in Dubai). The combination resulted in the
renaming of the Company to Mediclinic International plc.
The Mediclinic Group comprise 74 hospitals and 37 clinics. Mediclinic Southern Africa operates 49 hospitals and two day clinics
throughout South Africa and three hospitals in Namibia with more than 8 000 inpatient beds in total;
Hirslanden operates 16 private acute care facilities and four clinics in Switzerland with more than 1
600 inpatient beds; and Mediclinic Middle East operates six hospitals and 31 clinics with more than 700
inpatient beds in the United Arab Emirates.